阅读说明：本技术 用于治疗乙酰胆碱依赖性疾病的acefapc (ACEFAPC for the treatment of acetylcholine dependent diseases ) 是由 M·拉加德 E·维瑞塞尔 M·皮克 M·吉康丹 N·伯纳德-赫巴克 B·福莫 于 2018-03-08 设计创作，主要内容包括：本发明涉及用于在预防和治疗与乙酰胆碱缺乏相关联的疾病中使用的AceFaPC(1-乙酰基-2-脂肪酰基-甘油磷酰胆碱)。本发明还涉及该AceFaPC分子和包含该AceFaPC分子的药物组合物,在该AceFaPC分子中Fa表示包含至少14个碳原子的不饱和酰基。(The present invention relates to AceFaPC (1-acetyl-2-fatty acyl-glycerophosphorylcholine) for use in the prevention and treatment of diseases associated with acetylcholine deficiency. The invention also relates to the AceFaPC molecule, wherein Fa represents an unsaturated acyl group comprising at least 14 carbon atoms, and to a pharmaceutical composition comprising the AceFaPC molecule.)